Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results 2025-07-28 08:11
HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma 2025-07-23 20:36
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer 2025-04-10 10:00
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies 2025-02-26 08:03
Harbour BioMed Announces Business Progress and Update 2025-02-14 12:08
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-09-14 16:06
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
1